{"database": "lobbying", "table": "lobbying_activities", "rows": [[1513897, "ead87b6a-7f1e-4a37-a0e3-f957680d972c", "Q1", "THE WALTER GROUP", 309537, "AMERISOURCEBERGEN", 2014, "first_quarter", "MMM", "H.R. 800 & S. 806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP) Generally (in the context of Deficit Reduction). Oncology Innovation Project - Center for Medicare and Medicaid Innovation. Sequestration cuts to cancer care.H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2014-04-11T10:19:00.867000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1513897"], "units": {}, "query_ms": 25.622341025155038, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}